Key result
Conservative management of non-stenotic culprit lesions after a SUPER-MIMI strategy in STEMI patients resulted in a 7.0% rate of definite culprit lesion re-thrombosis at a mean of 4.1 years.
Why the study?
To assess whether a non-stenting strategy after a SUPER-MIMI strategy was safe at 4-year follow-up in STEMI patients who were not stented.
Is conservative management of non-stenotic culprit lesions safe in STEMI patients treated with a two-step reperfusion strategy?
Cohort (n=57)
Is conservative management of non-stenotic culprit lesions safe in STEMI patients treated with a two-step reperfusion strategy?
Conservative management of non-stenotic culprit lesions after a two-step reperfusion strategy in STEMI patients is associated with a high rate of re-thrombosis, especially in large coronary arteries.
Answers are grounded in this paper and cite their sources.
May warrant caution with conservative management after SUPER-MIMI; leaves open safety in STEMI and requires prospective trials.
Background: In the observational SUPER-MIMI study, a minimalist immediate mechanical intervention (MIMI) technique-which involves restoring blood flow in the acute phase and postponing stenting-was shown to be safe and effective among patients with a high thrombotic burden after ST-segment elevation myocardial infarction (STEMI). We aim to assess whether a non-stenting strategy after a SUPER-MIMI strategy was safe at 4-year follow-up in patients enrolled in the SUPER-MIMI study who were not stented. Methods: This prospective cohort study assessed the long-term outcomes of a subgroup of patients included in the SUPER-MIMI study. Results: Among the 155 patients enrolled in the SUPER-MIMI study, 57 patients (36.8%) benefited from a conservative management (without stenting or balloon angioplasty) and were included in the current substudy. The mean duration of follow-up was 4.1±1.0 years. Four patients (7.0%) presented definite culprit lesion re-thrombosis, all of which occurred in the right coronary artery. The re-thrombosis rate appeared to be higher among patients with larger vessels: 2.9%, 8.3%, and 28.6% in arteries with diameters of 3-<4, 4-<5, and ≥5 mm, respectively. The overall rate of target lesion revascularization was 10.5%. There was one cardiac death and three rehospitalizations for heart failure. Overall, 82.5% of patients remained event free at a mean of 4.1±1.0 years. Conclusions: Conservative management of non-stenotic culprit lesions after a SUPER-MIMI strategy was associated with a high rate of re-thrombosis, particularly in patients with large coronary arteries.
No takes yet. Share an insight, caveat, or question.
Bonnet et al. (2022) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=57). Conservative management (without stenting or balloon angioplasty) was evaluated on Definite culprit lesion re-thrombosis. Conservative management of non-stenotic culprit lesions after a SUPER-MIMI strategy in STEMI patients resulted in a 7.0% rate of definite culprit lesion re-thrombosis at a mean of 4.1 years.
Synapse has enriched 10 related papers. Consider them for comparative context: